Royal Bank of Canada’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $78K | Buy |
12,133
+283
| +2% | +$1.82K | ﹤0.01% | 5380 |
|
|
2025
Q1 | $42K | Sell |
11,850
-24
| -0.2% | -$85 | ﹤0.01% | 5255 |
|
|
2024
Q4 | $45K | Buy |
11,874
+24
| +0.2% | +$91 | ﹤0.01% | 5251 |
|
|
2024
Q3 | $38K | Sell |
11,850
-5,281
| -31% | -$16.9K | ﹤0.01% | 5358 |
|
|
2024
Q2 | $32K | Buy |
17,131
+15,779
| +1,167% | +$29.5K | ﹤0.01% | 5466 |
|
|
2024
Q1 | $3K | Sell |
1,352
-14,803
| -92% | -$32.8K | ﹤0.01% | 6116 |
|
|
2023
Q4 | $237K | Buy |
16,155
+8,060
| +100% | +$118K | ﹤0.01% | 4437 |
|
|
2023
Q3 | $148K | Buy |
8,095
+4,021
| +99% | +$73.5K | ﹤0.01% | 4590 |
|
|
2023
Q2 | $88K | Buy |
4,074
+446
| +12% | +$9.63K | ﹤0.01% | 4986 |
|
|
2023
Q1 | $107K | Sell |
3,628
-3,049
| -46% | -$89.9K | ﹤0.01% | 4749 |
|
|
2022
Q4 | $247K | Buy |
6,677
+5,304
| +386% | +$196K | ﹤0.01% | 4239 |
|
|
2022
Q3 | $38K | Buy |
1,373
+365
| +36% | +$10.1K | ﹤0.01% | 5383 |
|
|
2022
Q2 | $19K | Sell |
1,008
-3,286
| -77% | -$61.9K | ﹤0.01% | 5663 |
|
|
2022
Q1 | $56K | Buy |
+4,294
| New | +$56K | ﹤0.01% | 5524 |
|